Patents by Inventor Michael Andrew Carroll

Michael Andrew Carroll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8093405
    Abstract: An iodonium compound of formula (I): where RAR1 is a C5-6 aryl group, bearing at least one substituent selected from formyl, thionoacyl, acylamidocarboxy, thionoester, azo, C2-20 alkenyl, C2-20 alkynyl, and (CH2)nRC, where RC is selected from ether, amino, azo and thioether; RAR2 is a C5-10 aryl group, optionally substituted by one or more groups selected from C1-12 alkyl, C5-12 aryl, C3-12 heterocyclyl, ether, thioether, nitro, cyano and halo, and may be linked to a solid support or fluorous tag; and X is a counteranion.
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: January 10, 2012
    Assignee: University of Newcastle Upon Tyne
    Inventors: Michael Andrew Carroll, Ran Yan
  • Patent number: 7642373
    Abstract: Decomposition of iodonium salts by a free radical process has been identified as a significant factor in the observed yield variability of fluoridation reactions using said iodonium salts. Accordingly, the inclusion of a free radical trap in the reaction mixture blocks the radical chain decomposition pathway for iodonium salts such that only the reaction leading to fluoridation can occur and the yield of aryl fluoride becomes high and reproducible. The reaction may also be carried out on solid phase. In both the solution and the solid phase the preferred method of the present invention is radiofluoridation.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: January 5, 2010
    Assignee: GE Healthcare Limited
    Inventors: Harry John Wadsworth, David Arthur Widdowson, Emmanuelle Wilson, Michael Andrew Carroll
  • Publication number: 20090286992
    Abstract: An iodonium compound of formula (I): where RAR1 is a C5-6 aryl group, bearing at least one substituent selected from formyl, thionoacyl, acylamidocarboxy, thionoester, azo, C2-20 alkenyl, C2-20 alkynyl, and (CH2)nRC, where RC is selected from ether, amino, azo and thioether; RAR2 is a C5-10 aryl group, optionally substituted by one or more groups selected from C1-12 alkyl, C5-12 aryl, C3-12 heterocyclyl, ether, thioether, nitro, cyano and halo, and may be linked to a solid support or fluorous tag; and X is a counteranion.
    Type: Application
    Filed: May 15, 2009
    Publication date: November 19, 2009
    Inventors: Michael Andrew Carroll, Ran Yan
  • Patent number: 6458985
    Abstract: A process for the transformation of an organic molecule catalyzed by a ligand-metal complex, is conducted in compressed CO2 as a solvent, wherein the complex comprises a perfluorinated group. Further, a process for the polymerization of a monomer containing two or more polymerizable groups, optionally together with another copolymerizable monomer, to give a cross-linked polymer in the form of essentially spherical particles, is conducted in compressed CO2 as a solvent, typically in the presence of a surfactant.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: October 1, 2002
    Assignee: Cambridge University Technical Services, Ltd.
    Inventors: Andrew Bruce Holmes, Andrew Ian Cooper, Michael Andrew Carroll